dm+d
68887009
Articles
Using folic acid with methotrexate in rheumatoid arthritis
20 February 2023Folic acid is used to reduce methotrexate associated adverse effects in people with rheumatoid arthritis. This page guides appropriate dosing.
Methotrexate products: information for supporting intrathecal risk assessment
11 August 2022Methotrexate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Advising on missed or delayed doses of medicines
15 October 2021Guidance to advise people who occasionally forget or are late in taking a dose of their medicine(s).
Methotrexate monitoring
5 July 2021
What injections can be given orally or via enteral feeding tubes?
6 November 2020This updated Medicines Q&A is a quick reference summary to different types of enteral feeding tubes, in relation to medication issues. Not all enteral feeding…
Lactation Safety Information
For rheumatoid arthritis
For rheumatoid arthritis
See summary
Limited published evidence indicates small amounts in breast milk after weekly administration
Monitor infant’s blood count and do not resume breastfeeding until at least 24 hours after a weekly dose not exceeding 25mg
19 September 2019
For psoriasis
For psoriasis
Topical psoriasis preparation / corticosteroid if appropriate
Limited published evidence indicates small amounts in breast milk after weekly administration
Monitor infant’s blood count and do not resume breastfeeding until at least 24 hours after a weekly dose not exceeding 25mg
16 September 2019
For inflammatory bowel disease
For inflammatory bowel disease
See summary
Limited published evidence indicates small amounts in breast milk after weekly administration
Monitor infant’s blood count and do not resume breastfeeding until at least 24 hours after a weekly dose not exceeding 25mg
16 September 2019